Recent studies noting the successes of anti-estrogen treatments to patients with mammary hyperplasia or ERα-positive breast cancer [1], [10] supports that the estrogen signaling pathway plays an important role in the occurrence of mammary hyperplasia and breast cancer. This evidence concerns the gene ESR1 and breast carcinoma.